Decellularized scaffold hydrogel materials for mi treatment could "the matrix" really be the future?

Journal of the American College of Cardiology

Volumn 67, Issue 9, 2016, Pages 1087-1090

  Costa, Kevin D ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

biomaterial; extracellular matrix; heart failure; infarction; tissue engineering

Indexed keywords

CALCIUM ALGINATE; CAPTOPRIL; MYOCARDIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NKX2.5; TRANSCRIPTION FACTOR TBX5; HYDROGEL;

ACUTE HEART INFARCTION; AEROBIC METABOLISM; APOPTOSIS; BIOCOMPATIBILITY; BONE MARROW TRANSPLANTATION; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY BYPASS GRAFT; DRUG EFFECT; EXTRACELLULAR MATRIX; FATTY ACID METABOLISM; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CELL; HEART PROTECTION; HUMAN; HYDROGEL; INFLAMMATION; INJECTABLE IMPLANT; MITRAL VALVE REPAIR; MYOCARDIAL MATRIX HYDROGEL; NONHUMAN; NOTE; PIG; PRIORITY JOURNAL; PROTEIN EXPRESSION; THERAPY EFFECT; TISSUE ENGINEERING; TISSUE SCAFFOLD; ADMINISTRATION AND DOSAGE; ANGIOGENESIS; ANIMAL; CHEMISTRY; COMPLICATION; CORONARY ARTERY BLOOD FLOW; DRUG EFFECTS; FEMALE; HEART VENTRICLE REMODELING; PHYSIOLOGY;

ANIMALS; CORONARY CIRCULATION; EXTRACELLULAR MATRIX; FEMALE; HEART FAILURE; HYDROGEL; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; VENTRICULAR REMODELING;

EID: 84959302554     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.01.006     Document Type: Editorial

References (13)

1. D. Mozaffarian, E.J. Benjamin, A.S. Go, and et al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association Circulation 133 2016 e38 360
2. R. Delewi, A. Hirsch, J.G. Tijssen, and et al. Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis Eur Heart J 35 2014 989 998
3. K. Wei, V. Serpooshan, C. Hurtado, and et al. Epicardial FSTL1 reconstitution regenerates the adult mammalian heart Nature 525 2015 479 485
4. J.M. Singelyn, P. Sundaramurthy, T.D. Johnson, and et al. Catheter-deliverable hydrogel derived from decellularized ventricular extracellular matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction J Am Coll Cardiol 59 2012 751 763
5. S.B. Seif-Naraghi, J.M. Singelyn, M.A. Salvatore, and et al. Safety and efficacy of an injectable extracellular matrix hydrogel for treating myocardial infarction Sci Transl Med 5 2013 173ra25
6. J.W. Wassenaar, R. Gaetani, J.J. Garcia, and et al. Evidence for mechanisms underlying the functional benefits of a myocardial matrix hydrogel for post-MI treatment J Am Coll Cardiol 67 2016 1074 1086
7. G.C. Rowe, A. Jiang, and Z. Arany PGC-1 coactivators in cardiac development and disease Circ Res 107 2010 825 838
8. N. Sultana, L. Zhang, J. Yan, and et al. Resident c-kit(+) cells in the heart are not cardiac stem cells Nat Commun 6 2015 8701
9. P.L. Sanchez, M.E. Fernandez-Santos, S. Costanza, and et al. Acellular human heart matrix: a critical step toward whole heart grafts Biomaterials 61 2015 279 289
10. T.D. Johnson, R.C. Hill, M. Dzieciatkowska, and et al. Quantification of decellularized human myocardial matrix: a comparison of six patients Proteomics Clin Appl 10 2016 75 83
11. S.T. Wall, J.C. Walker, K.E. Healy, and et al. Theoretical impact of the injection of material into the myocardium: a finite element model simulation Circulation 114 2006 2627 2635
12. R.J. Lee, A. Hinson, R. Bauernschmitt, and et al. The feasibility and safety of Algisyl-LVR as a method of left ventricular augmentation in patients with dilated cardiomyopathy: initial first in man clinical results Int J Cardiol 199 2015 18 24
13. I.C. Turnbull, I. Karakikes, G.W. Serrao, and et al. Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium FASEB J 28 2014 644 654